Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Baltimore | 13,688 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,688 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2221-2240 of 13,688 trials

RecruitingA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTThis phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable…NCT04322318·Birmingham, Alabama and 204 others

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

CompletedStudy to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention ProgramTo measure the effectiveness of influenza vaccination in school children by comparing, between target(i.e., children are offered FluMist) and control (i.e., children are not…NCT00192218·Baltimore, Maryland and 1 other

CompletedStudy to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderThis is a randomized, double-blind, placebo-controlled, multicenter study to evaluate the effects of NMRA-335140 (formerly BTRX-335140) on symptoms of depression in participants…NCT06058013·Encino, California and 73 others

UnknownAn Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to RuxolitinibThis is a phase 1b/2 study of KRT-232 combined with ruxolitinib in subjects with MF who have a suboptimal response after at least 18 weeks of treatment with ruxolitinib.NCT04485260·Duarte, California and 37 others

CompletedFunctional Chewing Gum in Reduction of Gingival InflammationThe aim of this prospective randomized 3-month double-blinded single center study is to determine whether a chewing gum device with food additive chitosan, will aid in reducing…NCT03237624·Baltimore, Maryland

RecruitingA Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsThe REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators.NCT06504589·Birmingham, Alabama and 67 others

CompletedEffect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, concurrent with standard…NCT02973789·Birmingham, Alabama and 123 others

CompletedTreatment of CNS Sarcoidosis With H.P. Acthar GelThe purpose of this study is to see if treatment with H.P. Acthar® Gel will result in the improvement and long-term stabilization of clinical and radiographic abnormalities that…NCT02298491·Baltimore, Maryland

CompletedAlemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaRATIONALE: Monoclonal antibodies such as alemtuzumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00006390·Chicago, Illinois and 13 others

Active not recruitingA Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas CancerThe purpose of this study is to evaluate the safety and clinical activity of tislelizumab (an anti-PD-1 antibody) in combination with SX-682 (a CXCR1/2 inhibitor) in subjects with…NCT05604560·Baltimore, Maryland and 1 other

CompletedEffects of Energy DrinksThis study is designed to test the efficacy of energy drinks.NCT02727920·Baltimore, Maryland

CompletedA Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With HypercholesterolemiaThis Phase 1 study has been designed to evaluate the absolute bioavailability of PF-04950615 (RN316) in subjects with hypercholesterolemia who are not currently on lipid-lowering…NCT01435382·Chula Vista, California and 6 others

CompletedA Study of Ixazomib, Given With Dexamethasone in Adults With Multiple MyelomaThe main aim of this study is to learn if ixazomib, given with dexamethasone, stops the cancer from getting worse in people with relapsed or refractory multiple myeloma.NCT03170882·Fayetteville, Arkansas and 110 others

CompletedGLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 DiabetesObstructive Sleep Apnea (OSA) and type 2 diabetes mellitus are two prevalent medical conditions with significant associated cardiovascular and cerebrovascular morbidity and…NCT00509223·Mission Viejo, California and 14 others

CompletedPrevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)This study is a prospective, randomized, double-blind, placebo-controlled, multi-center trial to compare the efficacy and safety of celecoxib 400mg QD versus placebo in reducing…NCT00141193·San Diego, California and 105 others

RecruitingQuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerThis study will assess whether a quantitative, HER2 assay can accurately and reliably discriminate between responders and non-responders among patients with HER2 IHCI+ metastatic…NCT06551116·San Francisco, California and 36 others

CompletedRespiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSVThe purpose of this study is to provide critical information on the safety, reactogenicity and immunogenicity profile of the investigational recombinant chimpanzee adenovirus Type…NCT03636906·Atlanta, Georgia and 36 others

CompletedReduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)HLH, HLH-related disorders, Chronic Granulomatous (CGD), HIGM1, Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX) and severe LAD-I represent…NCT01998633·Birmingham, Alabama and 21 others

Active not recruitingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisThe goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving…NCT06001385·Phoenix, Arizona and 31 others

RecruitingOptimizing Reperfusion to Improve Outcomes and Neurologic FunctionThe goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care within 4.5 to 24 hours.NCT06990867·Long Beach, California and 103 others

PreviousPage 112 of 685Next

Diabetes

in Baltimore

Heart Diseasein Baltimore